Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
PRGO PRNewsWire — November 26, 2025BENSALEM, Pa. , Nov. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Primo Brands Corporation (PRMB) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
PRMB PRNewsWire — November 26, 2025BENSALEM, Pa. , Nov. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G.
WPP plc (WPP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
WPP PRNewsWire — November 26, 2025BENSALEM, Pa. , Nov. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Gold price could blow past $4,900/oz in 2026 if investors buy into diversification – Goldman Sachs' Struyven — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — November 26, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
CRMT Investor News: If You Have Suffered Losses in America's Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
CRMT GlobeNewsWire — November 26, 2025NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America's Car-Mart may have issued materially misleading business information to the investing public.
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
ATYR PRNewsWire — November 26, 2025LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). IF YOU SUFFERED A LOSS ON YOUR ATYR INVESTMENTS, CLICK HERE BEFORE DECEMBER 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Freeport-McMoran Inc. (FCX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
FCX PRNewsWire — November 26, 2025LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Freeport-McMoran Inc. ("Freeport" or the "Company") (NYSE: FCX) have opportunity to lead the securities fraud class action lawsuit.
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
BAX PRNewsWire — November 26, 2025LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX). IF YOU SUFFERED A LOSS ON YOUR BAXTER INVESTMENTS, CLICK HERE BEFORE DECEMBER 15, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
James Hardie Industries plc (JHX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
JHX PRNewsWire — November 26, 2025LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to James Hardie Industries plc ("James Hardie" or the "Company") (NYSE: JHX) have opportunity to lead the securities fraud class action lawsuit.
MLTX DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MLTX — Neutral
MLTX Newsfile Corp — November 26, 2025New York, New York--(Newsfile Corp. - November 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Firefly Aerospace Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FLY — Neutral
FLY Business Wire — November 26, 2025LOS ANGELES--(BUSINESS WIRE)--Firefly Aerospace Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FLY.
Portnoy Law Firm Announces Class Action on Behalf of Comerica, Inc. Investors — Neutral
CMA GlobeNewsWire — November 26, 2025LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Comerica, Inc., (“Comerica” or the "Company") (NYSE: CMA) investors off a class action on behalf of investors that bought securities in connection with the company's proposed acquisition by Fifth Third Bancorp.
Dan Ives: "Nvidia's World, Everyone Else is Paying Rent" — Positive
NVDA Schwab Network — November 26, 2025Dan Ives is back on The Watch List with Nicole Petallides to settle the Alphabet/Google (GOOGL) vs Nvidia (NVDA) debate. His team estimates that for every $1 spent on Nvidia, there is an $8-$10 multiplier across the rest of the tech ecosystem.
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised) — Positive
CVS UNH Zacks Investment Research — November 26, 2025CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Broadcom Q4 Earnings: 2 Accounting Details To Watch For — Positive
AVGO Seeking Alpha — November 26, 2025Broadcom Inc. is scheduled to announce its Q4 earnings report on December 11, 2025. Two AVGO potential issues worth monitoring are its treatment of recurring restructuring/integration costs and also stock-based compensation. AVGO's past treatment is debatable in my view and could overstate its true profitability.
Warner Bros. Sale: Paramount Has Edge, But Regulatory Hurdles Loom — Neutral
WBD Forbes — November 26, 2025Warner Bros. Discovery is officially on the block.
Aecom: When AI Actually Moves The Margin Needle But The Market Looks The Other Away — Positive
ACM Seeking Alpha — November 26, 2025Aecom (ACM) is undervalued after a post-earnings selloff, trading at 18.5x earnings and 12.0x EV/EBITDA, despite a strong transformation story. ACM is exiting low-margin construction management to focus on high-return advisory, AI-powered design tools, and aggressive share repurchases, aiming for margin expansion. Management is guiding for 6–8% organic NSR growth, 7% EBITDA growth, and 9% EPS growth for FY'26, with ambitious long-term targets for margin and EPS expansion.
Deere & Company remains a Hold as near-term fundamentals deteriorate despite strong Q4 revenue and past outperformance versus the S&P 500. DE's segments saw revenue growth but margin contraction, with rising production costs, tariffs, and weak agricultural markets pressuring profitability. Management expects a 5% revenue decline and a 13% profit drop for 2026, with agricultural demand and crop receipts projected to fall further.
Alphabet: Shares Rise Sharply For AI-Charged Company, But Still A Long-Term Play — Positive
GOOG GOOGL Seeking Alpha — November 26, 2025Alphabet (GOOGL) continues to outperform expectations, driven by AI initiatives and strong search revenue, recently surpassing $100 billion in quarterly revenue. Despite a sharp share price climb this year, GOOGL remains reasonably valued for long-term investors, with analyst targets near current levels but with rapid future growth expected. GOOGL's dividend is modest but poised for long-term growth, supported by robust buybacks and heavy AI-related capital investments leading to earnings and FCF.
SMX Turned Six Partnership Deals Into a Global Supply Chain Reset, Here's Why — Neutral
SMX Accesswire — November 26, 2025NEW YORK CITY, NY / ACCESS Newswire / November 26, 2025 / The past several months have not brought SMX (NASDAQ:SMX) normal momentum. They brought a shift.